Viewing Study NCT04379167


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2025-12-31 @ 5:03 PM
Study NCT ID: NCT04379167
Status: UNKNOWN
Last Update Posted: 2020-05-07
First Post: 2020-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module